Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study,Nucleosides, Nucleotides & Nucleic Acids

当前位置： X-MOL 学术 › Nucleosides Nucleotides Nucleic Acids › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study
Nucleosides, Nucleotides & Nucleic Acids ( IF 1.3 ) Pub Date : 2023-12-20 , DOI: 10.1080/15257770.2023.2296021
Yalda Hekmatshoar ₁ , Yalda Rahbar Saadat ₂ , Tulin Ozkan ₃ , Sureyya Bozkurt ₄ , Aynur Karadag Gurel ₅

Affiliation

Imatinib (IMA) and nilotinib are the first and second generations of BCR-ABL tyrosine kinase inhibitors, which widely applied in chronic myeloid leukemia (CML) treatment. Here we aimed to provide n...

中文翻译：